Current pharmacotherapeutic strategies for overactive bladder

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.7, 2002-07, pp. : 827-833

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The medical treatment of overactive bladder, including current and future treatments

By Athanasopoulos Anastasios Cruz Francisco

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 7, 2011-05 ,pp. : 1041-1055

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder

By Latini Jerilyn M Giannantoni Antonella

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 7, 2011-05 ,pp. : 1017-1027

Informa Healthcare

Access to resources Recommend Favorite

Emerging pharmacotherapeutic strategies for cholangiocarcinoma

By Dasanu Constantin A Majumder Shounak Trikudanathan Guru

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 12, 2011-08 ,pp. : 1865-1874

Informa Healthcare

Access to resources Recommend Favorite

Transdermal Oxybutynin: For Overactive Bladder

By Bang L.M. Easthope S.E. Perry C.M.

Drugs & Aging, Vol. 20, Iss. 11, 2003-01 ,pp. : 857-864

Adis International

Access to resources Recommend Favorite

Solifenacin in Overactive Bladder Syndrome

By Payne Christopher K.

Drugs, Vol. 66, Iss. 2, 2006-01 ,pp. : 175-190

Adis International

Access to resources Recommend Favorite